Clinical trial
A Food Effect Phase I Study of the Clifutinib in Healthy Subjects
NCT05454098 is registered in ClinicalTrials.gov with Sunshine Lake Pharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Food Effect Phase I Study of the Clifutinib in Healthy Subjects
- Lead sponsor
- Sunshine Lake Pharma Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 8, 2022
- Completion date
- December 8, 2022
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia in children